Objective To investigate evolving patterns in antithrombotic treatment in UK patients with
newly diagnosed non-valvular atrial fibrillation (AF). Design Prospective, multicentre, …

The Global Anticoagulant Registry in the Field-Atrial Fibrillation (GARFIELD-AF) examined
real-world practice in a total of 57,149 (5069 retrospective, 52,080 prospective) patients with …

Objective To examine patients' understanding of hospital-associated thrombosis, and their
experiences of thromboprophylaxis. Design Qualitative study using semi-structured interviews …

Background Atrial fibrillation (AF) is an independent risk factor for stroke and a significant
predictor of mortality. Evidence-based guidelines for stroke prevention in AF recommend …

Background The outcomes of patients newly diagnosed with atrial fibrillation (AF) following
the introduction of direct-acting oral anticoagulants are not well known. Aim To determine the …

Background Care home residents have venous thromboembolism (VTE) risk profiles similar
to medical inpatients; however, the epidemiology of VTE in care homes is unclear. Aim To …

… Patricia N Apenteng, research fellow in applied health research, … Uptake of training in
point-of-care ultrasonography has been slow in UK medical schools, but it should be included in …

Background The GARFIELD-AF tool is a novel risk tool that simultaneously assesses the
risk of all-cause mortality, stroke or systemic embolism, and major bleeding in patients with …

… In total, 3574 patients were prospectively enrolled to the UK study, comprising 6.9% (n =
3574/52 057) of the global cohort. Of these, 2.5% (… In total, 12.5% (n = 447/3564) received …

This thesis brings together research undertaken by the author on prevention of two thrombotic
disease conditions: atrial fibrillation (AF) related stroke and venous thromboembolism (…